
Overview
Dr. Steve Braunstein is a radiation oncologist who cares for both adult and pediatric patients. He specializes in treating brain and spinal tumors, sarcomas, lymphoma and pediatric cancers. He also provides palliative radiotherapy to reduce symptoms in patients with advanced cancer. His expertise encompasses a number of technologies that use radiation as therapy, with a special focus on intraoperative radiotherapy and radiosurgery – using targeted high-dose radiation to destroy tumors, either as an alternative to surgical procedures or in combination with them. Braunstein's primary areas of research include improving radiation planning and treatment through the use of both gene marker analysis and advanced imaging technologies. He also studies how to improve the coordination, timing and delivery of health care that involves a variety of disciplines, including symptom management and cancer specialties. After earning his medical degree as well as a doctorate in biomedical sciences at New York University School of Medicine, Braunstein completed a residency in radiation oncology at UCSF. Braunstein is program director of UCSF's residency program and has a special interest in educating residents and medical students. He received a UCSF Medical Center Exceptional Physician Award in 2013. Braunstein serves as an editor for the International Journal of Radiation Oncology, Biology and Physics. He belongs to the American Society for Radiation Oncology, American Society of Clinical Oncology, Children's Oncology Group, Radiological Society of North America, North American Skull Base Society, International Gamma Knife Research Foundation and International Stereotactic Radiosurgery Society. He is active on committees within the National Cancer Institute, Children's Oncology Group and NRG Oncology.
Dr. Braunstein is highly rated in 38 conditions, according to our data. His top areas of expertise are Meningioma, Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Osteotomy.
His clinical research consists of co-authoring 201 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MEDICARE DISCOUNT CARD
- MEDICARE MAPD
Locations
1600 Divisadero St., Basement Level, San Francisco, CA 94115
505 Parnassus Ave., Room L-75, San Francisco, CA 94143
1825 Fourth St., First Floor, Room L1101, San Francisco, CA 94158
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Adult Neurofibromatosis Type 1 (NF1) And Schwannomatosis Clinic
Dr. David Raleigh is a radiation oncologist who specializes in brain tumors. He cares for both adult and pediatric patients. Raleigh's research focuses on understanding the biological processes that cause brain tumors to grow. His goals are to uncover new measures of brain cancer and to identify cells for drugs to target. Raleigh earned a bachelor's degree in molecular and cell biology as well as a bachelor's degree in cognitive science from the University of California, Berkeley. He earned his doctoral degree in molecular pathogenesis – how disease develops at the molecular level – from the University of Chicago, followed by his medical degree from the Pritzker School of Medicine at the University of Chicago. He completed a residency in radiation oncology at UCSF. Raleigh is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, Pacific Pediatric Neuro-Oncology Consortium, Children's Oncology Group, Society for Neuro-Oncology, International Meningioma Society and North American Skull Base Society. At the UCSF Brain Tumor Center, Raleigh is a principal investigator with the Wolfe Meningioma Program Project. Dr. Raleigh is highly rated in 22 conditions, according to our data. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.
Melanoma & Skin Cancer Center
Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants. Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center. Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research. Dr. Yom is highly rated in 28 conditions, according to our data. Her top areas of expertise are Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Merkel Cell Carcinoma, and Olfactory Neuroblastoma.
Stanford Health Care
Richard Hoppe is a Radiation Oncologist in Stanford, California. Dr. Hoppe is highly rated in 15 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Mycosis Fungoides, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Cutaneous T-Cell Lymphoma (CTCL).
Frequently Asked Questions about Dr. Steve Braunstein
How do I make an appointment with Dr. Steve Braunstein?
You can book an appointment with Dr. Steve Braunstein by calling their office at 415-353-7175. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Steve Braunstein a top-rated expert for Meningioma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steve Braunstein is classified as an Elite expert for Meningioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Steve Braunstein specialize in?
While Dr. Steve Braunstein is a Radiation Oncology, they have specific expertise in Meningioma, Brain Tumor, and Posterior Fossa Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Steve Braunstein participate in research or clinical trials?
Yes. Dr. Steve Braunstein has published 201 articles and abstracts on conditions like Meningioma. You can view a list of Dr. Steve Braunstein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Steve Braunstein accept my insurance?
Dr. Steve Braunstein accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-353-7175 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Brain TumorDr. Braunstein isElite. Learn about Brain Tumor.
- MeningiomaDr. Braunstein isElite. Learn about Meningioma.
- Distinguished
- Acoustic NeuromaDr. Braunstein isDistinguished. Learn about Acoustic Neuroma.
- Adult Soft Tissue SarcomaDr. Braunstein isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- AstrocytomaDr. Braunstein isDistinguished. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Braunstein isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Bone TumorDr. Braunstein isDistinguished. Learn about Bone Tumor.
- Embryonal Tumor with Multilayered RosettesDr. Braunstein isDistinguished. Learn about Embryonal Tumor with Multilayered Rosettes.
- Advanced
- Alveolar Soft Part SarcomaDr. Braunstein isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- Arteriovenous MalformationDr. Braunstein isAdvanced. Learn about Arteriovenous Malformation.
- ChordomaDr. Braunstein isAdvanced. Learn about Chordoma.
- Epithelioid SarcomaDr. Braunstein isAdvanced. Learn about Epithelioid Sarcoma.
- Familial Prostate CancerDr. Braunstein isAdvanced. Learn about Familial Prostate Cancer.
- FibrosarcomaDr. Braunstein isAdvanced. Learn about Fibrosarcoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Braunstein isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adrenal CancerDr. Braunstein isExperienced. Learn about Adrenal Cancer.
- ALK-Positive Non-Small Cell Lung CancerDr. Braunstein isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AngiosarcomaDr. Braunstein isExperienced. Learn about Angiosarcoma.
- Brain Stem CancerDr. Braunstein isExperienced. Learn about Brain Stem Cancer.
- Breast CancerDr. Braunstein isExperienced. Learn about Breast Cancer.


